| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |